> Hot topics in breast cancer care: Hormone replacement therapy and shared decision-making

Hot topics in breast cancer care: Hormone replacement therapy and shared decision-making

A webinar for healthcare providers

An older woman with glasses and her female, Black doctor smile at each other in a doctor's office.

Date and Time

Wed, Aug 19, 2026 12:00 pm to 1:00 pm ET | Add to Calendar

Location

Virtual

Cost

Free

Register now

Continuing education available

Earn up to:

  • 1.0 AMA PRA Category 1 Credit™ (Physicians)
  • 1.0 ANCC contact hour (Nurses)
  • 1.0 ASWB ACE continuing education credit (Social Workers)

The activity will also be available as an enduring course for 12 months following the live webinar for eligible learners.

Click here for full accreditation details (PDF)

Date and Time

Wed, Aug 19, 2026 12:00 pm to 1:00 pm ET | Add to Calendar

Location

Virtual

Cost

Free

Register now

Continuing education available

Earn up to:

  • 1.0 AMA PRA Category 1 Credit™ (Physicians)
  • 1.0 ANCC contact hour (Nurses)
  • 1.0 ASWB ACE continuing education credit (Social Workers)

The activity will also be available as an enduring course for 12 months following the live webinar for eligible learners.

Click here for full accreditation details (PDF)

general_content

Join us for a practical discussion that combines the latest clinical evidence with the real questions we’re hearing from the breast cancer community. Together, we’ll explore hormonal and non-hormonal approaches to symptom management, considerations for hormone replacement therapy, and communication strategies that help patients understand their options and make decisions that reflect their individual needs, concerns, and priorities.

on_this_page
general_content

Learn together

The live webinar gives you the opportunity to ask questions and connect with oncology professionals from across the country who are navigating these same conversations with patients.

After this webinar, you’ll be able to:

  • Describe the role of HRT in managing breast cancer-related menopausal symptoms.
  • Identify hormonal and non-hormonal options for symptom management.
  • Identify the relative contraindications and cautions for HRT use with patients.
  • Explain patients’ practical and emotional concerns about coping with menopause.
  • Apply strategies for shared decision-making with patients.
general_content

Continuing education available

Earn up to:

  • 1.0 AMA PRA Category 1 Credit™ (Physicians)
  • 1.0 ANCC contact hour (Nurses)
  • 1.0 ASWB ACE continuing education credit (Social Workers)
general_content

Can’t attend live? Register anyway. The webinar will also be available as an enduring activity for 12 months following the live event. More details about the enduring activity will be provided closer to the live webinar date.

speakers_feature

About our speakers

Dani Binnington

Dani Binnington

Founder, Menopause and Cancer

Dani Binnington is the founder of Menopause and Cancer. When she was diagnosed with cancer at 33, she was not thinking about helping others navigate menopause after cancer. She was focused on seeing her three young daughters walk through the school gates. Today, she is an advocate for people navigating menopause after cancer.

Read more
Dr. Corinne Menn

Corinne Menn, DO, FACOG, MSCP

OB-GYN and Menopause Specialist

Dr. Corinne Menn is a board-certified OB-GYN and Menopause Society Certified Practitioner. A person treated for breast cancer and premature menopause, she brings together clinical expertise and lived experience in her work focused on menopause, sexual health, and cancer survivorship.

Read more
speakers_feature

About our moderator

Michelle Bronzo

Michelle Bronzo, MA, LPC, LCPC, LMHC, CT, FT

Psychotherapist, Michelle Bronzo Counseling, LLC

Michelle Bronzo, MA, LPC, LCPC, LMHC, CT, FT, is a licensed clinical professional counselor based in Potomac, Maryland, with a private practice specializing in grief, loss, and oncology counseling.

Read more
general_content

This project is supported by Grant/Cooperative Agreement Number NU58DP007913 from the Centers for Disease Control and Prevention. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention.

related_resources_article_carousel

Related resources

upcoming_events
stay_connected

Stay connected

Sign up to receive emotional support, medical insight, personal stories, and more, delivered to your inbox weekly.